Who Owns IKT?

Inhibikase Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$1.89

+0.03 (+1.61%)

Market Cap

$134.2M

Shares Outstanding

71,002,953

Institutional Holders

47

Total Inst. Value

$110.6M

% of Float Held

123.6%

QoQ Holder Change

+35

Institutional data as of Q1 2025

New Positions

19

Closed Positions

4

Increased

12

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Sands Capital Alternatives, LLC$24.0M10,950,000
2Soleus Capital Management, L.P.$13.9M6,325,000
3Fairmount Funds Management LLC$13.4M6,125,000
4PERCEPTIVE ADVISORS LLC$13.0M5,925,000
5Commodore Capital LP$11.7M5,344,432
6ADAR1 Capital Management, LLC$11.2M5,122,105
7VANGUARD GROUP INC$6.2M2,848,663
8Nantahala Capital Management, LLC$4.8M2,190,000
9Blackstone Inc.$4.5M2,070,684
10Stonepine Capital Management, LLC$2.0M914,973

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
Commodore Capital LP-581K$11.7M
Stonepine Capital Management, LLC-217K$2.0M
CITIGROUP INC-51K$56K

Related Stocks

Frequently Asked Questions

How many institutional investors hold IKT?

As of Q1 2025, 47 institutional investors report holding IKT (Inhibikase Therapeutics, Inc.) in their 13F filings.

What percentage of Inhibikase Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 123.6% of Inhibikase Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most IKT?

The largest institutional holder of IKT is Sands Capital Alternatives, LLC with $24.0M in shares.

Are institutions buying or selling IKT?

This quarter, 19 institutions opened new positions in IKT and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.